Damien J LaPar1, Alan M Speir2, Ivan K Crosby1, Edwin Fonner3, Michael Brown4, Jeffrey B Rich5, Mohammed Quader6, John A Kern1, Irving L Kron1, Gorav Ailawadi7. 1. Department of Cardiothoracic Surgery, University of Virginia, Charlottesville, Virginia. 2. Department of Cardiothoracic Surgery, Inova Heart and Vascular Institute, Falls Church, Virginia. 3. Department of Cardiothoracic Surgery, Virginia Cardiac Surgery Quality Initiative, Charlottesville, Virginia. 4. Department of Cardiothoracic Surgery, Mary Washington Hospital, Fredericksburg, Virgina. 5. Department of Cardiothoracic Surgery, Sentara Heart Hospital, Norfolk, Virginia. 6. Department of Cardiothoracic Surgery, Medical College of Virginia, Richmond, Virginia. 7. Department of Cardiothoracic Surgery, University of Virginia, Charlottesville, Virginia. Electronic address: gorav@virginia.edu.
Abstract
BACKGROUND: New-onset postoperative atrial fibrillation (POAF) is the most common complication following cardiac surgery. However, the magnitude of POAF on length of stay, resource utilization, and readmission rates remains an area of clinical interest. The purpose of this study was to examine the risk-adjusted impact of POAF on measures of mortality, hospital resources, and costs among multiple centers. METHODS: A total of 49,264 patient records from a multi-institutional Society of Thoracic Surgeons (STS) certified database for cardiac operations (2001 to 2012) were extracted and stratified by the presence of POAF (19%) versus non-POAF (81%). The influence of POAF on outcomes was assessed by hierarchic regression modeling, adjusted for calculated STS predictive risk indices. RESULTS: Mean age was 64±11 years, and median STS predicted risk of mortality for patients who developed POAF were incrementally higher (2% vs 1%, p<0.001) compared with non-POAF patients. The rate of POAF was highest among those undergoing aortic valve replacement+coronary artery bypass grafting, aortic valve, and mitral valve replacement operations. The POAF patients had a higher unadjusted incidence of mortality, morbidity, hospital readmission, longer intensive care unit (ICU) and postoperative length of stay, and higher hospital costs. After risk adjustment, POAF was associated with a twofold increase in the odds of mortality (adjusted odds ratio=2.04, p<0.001), greater hospital resource utilization, and increased costs; POAF was associated with 48 additional ICU hours (p<0.001), 3 additional hospital days (p<0.001), and $3,000 (p<0.001) and $9,000 (p<0.001) of increased ICU and total hospital-related costs, respectively. CONCLUSIONS: New onset POAF is associated with increased risk-adjusted mortality, hospital costs, and readmission rates. Protocols to reduce the incidence of POAF have the potential to significantly impact patient outcomes and the delivery of high-quality, cost-effective patient care.
BACKGROUND: New-onset postoperative atrial fibrillation (POAF) is the most common complication following cardiac surgery. However, the magnitude of POAF on length of stay, resource utilization, and readmission rates remains an area of clinical interest. The purpose of this study was to examine the risk-adjusted impact of POAF on measures of mortality, hospital resources, and costs among multiple centers. METHODS: A total of 49,264 patient records from a multi-institutional Society of Thoracic Surgeons (STS) certified database for cardiac operations (2001 to 2012) were extracted and stratified by the presence of POAF (19%) versus non-POAF (81%). The influence of POAF on outcomes was assessed by hierarchic regression modeling, adjusted for calculated STS predictive risk indices. RESULTS: Mean age was 64±11 years, and median STS predicted risk of mortality for patients who developed POAF were incrementally higher (2% vs 1%, p<0.001) compared with non-POAF patients. The rate of POAF was highest among those undergoing aortic valve replacement+coronary artery bypass grafting, aortic valve, and mitral valve replacement operations. The POAF patients had a higher unadjusted incidence of mortality, morbidity, hospital readmission, longer intensive care unit (ICU) and postoperative length of stay, and higher hospital costs. After risk adjustment, POAF was associated with a twofold increase in the odds of mortality (adjusted odds ratio=2.04, p<0.001), greater hospital resource utilization, and increased costs; POAF was associated with 48 additional ICU hours (p<0.001), 3 additional hospital days (p<0.001), and $3,000 (p<0.001) and $9,000 (p<0.001) of increased ICU and total hospital-related costs, respectively. CONCLUSIONS: New onset POAF is associated with increased risk-adjusted mortality, hospital costs, and readmission rates. Protocols to reduce the incidence of POAF have the potential to significantly impact patient outcomes and the delivery of high-quality, cost-effective patient care.
Authors: Michael P O'Quinn; Kenneth J Dormer; Jose F Huizar; Kytai T Nguyen; Karoly Kaszala; Adam Sima; Kenneth A Ellenbogen; Alex Y Tan Journal: Heart Rhythm Date: 2019-04 Impact factor: 6.343
Authors: Ethan J Anderson; Jimmy T Efird; Andy C Kiser; Patricia B Crane; Wesley T O'Neal; T Bruce Ferguson; Hazaim Alwair; Kendal Carter; J Mark Williams; Anil K Gehi; Alan P Kypson Journal: JACC Clin Electrophysiol Date: 2017-04-26
Authors: Robert B Hawkins; J Hunter Mehaffey; Abra Guo; Eric J Charles; Alan M Speir; Jeffrey B Rich; Mohammed A Quader; Gorav Ailawadi; Leora T Yarboro Journal: J Thorac Cardiovasc Surg Date: 2018-04-18 Impact factor: 5.209
Authors: Miklos D Kertai; Wenjing Qi; Yi-Ju Li; Frederick W Lombard; Yutao Liu; Michael P Smith; Mark Stafford-Smith; Mark F Newman; Carmelo A Milano; Joseph P Mathew; Mihai V Podgoreanu Journal: J Mol Cell Cardiol Date: 2016-02-06 Impact factor: 5.000
Authors: Jimmy T Efird; Preeti Gudimella; Wesley T O'Neal; William F Griffin; Hope Landrine; Linda C Kindell; Stephen W Davies; Daniel F Sarpong; Jason B O'Neal; Patricia Crane; Margaret A Nelson; Thomas Bruce Ferguson; Walter Randolph Chitwood; Alan P Kypson; Ethan J Anderson Journal: Am J Cardiol Date: 2016-01-15 Impact factor: 2.778
Authors: Jimmy T Efird; Andy C Kiser; Patricia B Crane; Hope Landrine; Linda C Kindell; Margaret-Ann Nelson; Charulata Jindal; Daniel F Sarpong; William F Griffin; T Bruce Ferguson; W Randolph Chitwood; Stephen W Davies; Alan P Kypson; Preeti Gudimella; Ethan J Anderson Journal: Pharmacotherapy Date: 2017-02-03 Impact factor: 4.705
Authors: Gregory P Giambrone; Xian Wu; Licia K Gaber-Baylis; Akshay U Bhat; Ramin Zabih; Nasser K Altorki; Peter M Fleischut; Brendon M Stiles Journal: J Thorac Cardiovasc Surg Date: 2015-12-12 Impact factor: 5.209